Skip to main content
Clinical Trials/NCT03348995
NCT03348995
Active, not recruiting
Not Applicable

A Prospective Cohort Clinical Trial Evaluating Age as a Risk Factor for Poor Outcomes of Bridge-Enhanced ACL Restoration (BEAR)

Miach Orthopaedics11 sites in 1 country250 target enrollmentApril 17, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anterior Cruciate Ligament Injury
Sponsor
Miach Orthopaedics
Enrollment
250
Locations
11
Primary Endpoint
International Knee Documentation Committee Objective Score (IKDC) (Physical Exam)
Status
Active, not recruiting
Last Updated
4 months ago

Overview

Brief Summary

Bridge-Enhanced ACL Restoration (BEAR) is a new procedure being developed to treat patients with ACL injuries. In the BEAR procedure, an implant is placed between the torn ends of the ACL and the patient's own blood is added to the implant to stimulate ligament healing. We propose the current study to determine if older patients do better than younger patients (or vice versa) with this procedure. This is a cohort study designed to determine if age is a risk factor for a worse outcome after a bridge-enhanced ACL repair (BEAR) as defined by an 11.5 point difference on the IKDC Subjective or Objective Knee Evaluation score at two years after surgery. Additional objectives are to determine the effect of age on safety outcomes including infection, graft rejection, and need for further surgical procedures.

Detailed Description

The BEAR III study is a cohort study designed to determine if age is a risk factor for a worse outcome after a bridge-enhanced ACL restoration (BEAR) as defined by an 11.5 point difference on the IKDC Subjective or Objective Knee Evaluation score at two years after surgery. Additional objectives are to determine the effect of age on safety outcomes including infection, graft rejection, and need for further surgical procedures.

Registry
clinicaltrials.gov
Start Date
April 17, 2018
End Date
April 17, 2034
Last Updated
4 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Miach Orthopaedics
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • ACL tear, within 50 days of injury, at least 5% of the ACL attached to the tibia.

Exclusion Criteria

  • Prior surgery on the affected knee, history of knee infection, use of tobacco, use of corticosteroid, chemotherapy, allergy to bovine products or gelatin, history of anaphylaxis, BMI over 35, moderate osteoarthritis.

Outcomes

Primary Outcomes

International Knee Documentation Committee Objective Score (IKDC) (Physical Exam)

Time Frame: Time points up to two years.

This is an examination performed of the knee. Scores are one of four measures: A (Normal), B (Nearly Normal), C (Abnormal) and D (Severely Abnormal). A is the best outcome and D is the worst.

International Knee Documentation Committee Subjective Score (IKDC) (Survey)

Time Frame: Time points up to two years

This is a survey patients complete about how their knee is feeling and functioning. Range is 0 to 100, with 100 indicating no problems and 0 indicating extreme problems.

Secondary Outcomes

  • Repair Failure(Two years)
  • Knee Injury and Osteoarthritis Score (KOOS) questionnaire(Time points up to two years)

Study Sites (11)

Loading locations...

Similar Trials